248 related articles for article (PubMed ID: 1410753)
1. [Prophylaxis with dantrolene sodium in 2 patients with susceptibility to malignant hyperthermia].
Navas E; Sánchez-Peña J; Gutiérrez-Crespo A
Rev Esp Anestesiol Reanim; 1992; 39(5):309-11. PubMed ID: 1410753
[TBL] [Abstract][Full Text] [Related]
2. [Transient normalisation of CK blood levels in patients susceptible to malignant hyperthermia by oral administration of dantrolene (author's transl)].
Bernhardt D
Anaesthesist; 1982 May; 31(5):252-4. PubMed ID: 7103034
[TBL] [Abstract][Full Text] [Related]
3. Dantrolene sodium in the management of patients at risk from malignant hyperthermia.
Bronstein SL; Ryan DE; Solomons CC; Mahowald MC
J Oral Surg; 1979 Oct; 37(10):719-24. PubMed ID: 289734
[TBL] [Abstract][Full Text] [Related]
4. Malignant hyperthermia susceptibility--successful management with a "stressfree" technique.
Jantzen JP; Erdmann K; Kleemann PP
Acta Anaesthesiol Belg; 1987; 38(1):107-13. PubMed ID: 3591264
[TBL] [Abstract][Full Text] [Related]
5. [Anaesthesia in a patient susceptible to malignant hyperthermia (author's transl)].
Schuh FT; Maier C
Anaesthesist; 1982 May; 31(5):245-7. PubMed ID: 7103032
[TBL] [Abstract][Full Text] [Related]
6. [An attempt to reconcile differences of opinion in the field of malignant hyperthermia].
Schulte-Sasse U; Eberlein HJ
Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):464-7. PubMed ID: 1786307
[TBL] [Abstract][Full Text] [Related]
7. Malignant hyperthermia and the otolaryngologist.
Chang CY; Scher RL
Ear Nose Throat J; 2003 Jun; 82(6):433-6. PubMed ID: 12861868
[TBL] [Abstract][Full Text] [Related]
8. [The use of subarachnoid bupivacaine analgesia in malignant hyperthermia-susceptible subjects. A clinical case report].
Abballe C; Primieri P; De Cosmo G
Minerva Anestesiol; 1993 Jun; 59(6):335-8. PubMed ID: 8414095
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic use of dantrolene associated with prolonged postanesthetic recumbency in a horse.
Valverde A; Boyd CJ; Dyson DH; Pascoe PJ
J Am Vet Med Assoc; 1990 Oct; 197(8):1051-3. PubMed ID: 2243040
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of susceptibility to malignant hyperthermia in pregnancy.
Sorosky JI; Ingardia CJ; Botti JJ
Am J Perinatol; 1989 Jan; 6(1):46-8. PubMed ID: 2910318
[TBL] [Abstract][Full Text] [Related]
11. General anesthesia in a malignant hyperthermia susceptible patient.
Jones JE; Dierdorf SF; Clapp DW
J Oral Med; 1987; 42(1):22-4, 66. PubMed ID: 2950215
[No Abstract] [Full Text] [Related]
12. [Caesarean section in a patient with past history of fulminant malignant hyperthermia].
Goto S; Ogata K; Fujie T; Fujigaki T; Nakamura H; Yukinari T; Shibata O
Masui; 1993 Feb; 42(2):271-5. PubMed ID: 8437362
[TBL] [Abstract][Full Text] [Related]
13. Effective use of dantrolene in a patient susceptible to malignant hyperthermia.
Gallagher DM; Hyer RL
J Oral Surg; 1980 Jun; 38(6):438-40. PubMed ID: 6929328
[No Abstract] [Full Text] [Related]
14. Pre-anaesthetic administration of dantrolene sodium to a patient at risk from malignant hyperthermia: case report.
Free CW; Jaimon MP
N Z Med J; 1978 Dec; 88(626):493-4. PubMed ID: 283330
[TBL] [Abstract][Full Text] [Related]
15. [Fulminant malignant hyperthermia during the 6th general anesthesia using volatile anesthetics].
Striebel HW; Lechner J; Wiegand C; Hartung E
Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):475-80. PubMed ID: 1786310
[TBL] [Abstract][Full Text] [Related]
16. Successful use of dantrolene sodium in human malignant hyperthermia syndrome: a case report.
Friesen CM; Brodsky JB; Dillingham MF
Can Anaesth Soc J; 1979 Jul; 26(4):319-21. PubMed ID: 509349
[TBL] [Abstract][Full Text] [Related]
17. Dantrolene sodium is able to reduce the resting ionic [Ca2+]i in muscle from humans with malignant hyperthermia.
López JR; Medina P; Alamo L
Muscle Nerve; 1987 Jan; 10(1):77-9. PubMed ID: 3561441
[TBL] [Abstract][Full Text] [Related]
18. [Postoperative respiratory depression thought to be due to oral dantrolene pretreatment in a malignant hyperthermia-susceptible patient].
Hara Y; Kato A; Horikawa H; Kato Y; Ichiyanagi K
Masui; 1988 Apr; 37(4):483-7. PubMed ID: 3398231
[No Abstract] [Full Text] [Related]
19. [Malignant hyperthermia in Austria. III. Anesthesia in susceptible patients].
Mauritz W; Hackl W; Sporn P; Steinbereithner K
Anaesthesist; 1988 Aug; 37(8):522-8. PubMed ID: 3177878
[TBL] [Abstract][Full Text] [Related]
20. Malignant hyperthermia.
Moore JL; Rice EL
Am Fam Physician; 1992 May; 45(5):2245-51. PubMed ID: 1575119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
